Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178879-23-000016
Filing Date
2023-11-08
Accepted
2023-11-08 16:02:08
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fold-20230930.htm   iXBRL 10-Q 1083137
2 EX-10.3 exhibit103-simonharfordemp.htm EX-10.3 105185
3 EX-31.1 fold-09302023xex311.htm EX-31.1 11059
4 EX-31.2 fold-09302023xex312.htm EX-31.2 11135
5 EX-32.1 fold-09302023xex321.htm EX-32.1 8566
  Complete submission text file 0001178879-23-000016.txt   6018809

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20230930.xsd EX-101.SCH 31716
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20230930_cal.xml EX-101.CAL 66565
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20230930_def.xml EX-101.DEF 153357
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fold-20230930_lab.xml EX-101.LAB 577744
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20230930_pre.xml EX-101.PRE 372630
61 EXTRACTED XBRL INSTANCE DOCUMENT fold-20230930_htm.xml XML 791137
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 231387688
SIC: 2834 Pharmaceutical Preparations